SAFC preparing for inevitable shift to cell culture vaccines

By Nick Taylor

- Last updated on GMT

Related tags: Influenza

SAFC preparing for inevitable shift to cell culture vaccines
SAFC Pharma is preparing for the shift towards cell culture-based vaccines, while still supplying and growing in the traditional sector, to ensure it can grow in coming years, according to a company director.

Speaking to in-PharmaTechnologist David Backer, director of business development and marketing at SAFC Pharma, said that the level of funds the US government has put into cell culture means it is certain to become mainstream.

Consequently, SAFC is preparing for this shift and equipping itself to provide products and services for next generation vaccines. This will ensure it can meet the changing demands of the seasonal flu market, as well as dealing with pandemics as they occur, and continue growing.

Related news

Show more

Related products

show more

A Better Approach, for Better Pain Trials

A Better Approach, for Better Pain Trials

Signant Health | 27-Sep-2021 | Technical / White Paper

Pain studies face unique challenges. For one, pain severity can only be truly assessed by the patients themselves. The controlled substances that are often...

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Related suppliers

Follow us

Products

View more

Webinars